C. Daniel Myers compensation by year
ALIMERA SCIENCES Summary Compensation Table · all 2 fiscal years held| Component | FY2018 | FY2019 |
|---|---|---|
| Salary | $600,000 | $0 |
| Bonus | $0 | $0 |
| Stock awards | $143,956 | $0 |
| Option awards | $306,734 | $27,753 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $6,097 | $802,500 |
| Total | $1,056,787 | $830,253 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ALIMERA SCIENCES INC DEF 14A filed April 29, 2020, accession 0001267602-20-000063, and prior-year filings. Open the filing on EDGAR.
How this page was built: the ALIMERA SCIENCES INC filed document, accession 0001267602-20-000063. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2020.
ALIMERA SCIENCES’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Richard Eiswirth | President, Chief Executive Officer and Former Chief Financial Officer (1) President, Chief Executive Officer and Former Chief Financial Officer (1) | $977,025 |
| C. Daniel Myers · this page | Chairman of the Board and Former Chief Executive Officer (2) Chairman of the Board and Former Chief Executive Officer (2) | $830,253 |
| David Holland | Chief Marketing Officer, Senior Vice President Corporate Communications and Managed Markets | $576,458 |
| Philip Ashman | Chief Operating Officer and Senior Vice President Commercial Operations Europe (3)(4) | $553,179 |
The full ALIMERA SCIENCES compensation record
free company briefThis page is one person within ALIMERA SCIENCES's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ALIMERA SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.